CoChat

Pharmacology of ayahuasca administered in two repeated doses

dos Santos, Rafael G., Grasa, Eva, Valle, Marta, Ballester, Maria Rosa, Bouso, José Carlos, Nomdedéu, Josep F., Homs, Rosa, Barbanoj, Manel J., Riba, Jordi · 2012 · Psychopharmacology

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Abstract

Rationale Ayahuasca is an Amazonian tea containing the natural psychedelic 5-HT(2A/2C/1A) agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its visionary properties. The human pharmacology of ayahuasca has been well characterized following its administration in single doses. Objectives To evaluate the human pharmacology of ayahuasca in repeated doses and assess the potential occurrence of acute tolerance or sensitization. Methods In a double-blind, crossover, placebo-controlled clinical trial, nine experienced psychedelic drug users received PO the two following treatment combinations at least 1 week apart: (a) a lactose placebo and then, 4 h later, an ayahuasca dose; and (b) two ayahuasca doses 4 h apart. All ayahuasca doses were freeze-dried Amazonian-sourced tea encapsulated to a standardized 0.75 mg DMT/kg bodyweight. Subjective, neurophysiological, cardiovascular, autonomic, neuroendocrine, and cell immunity measures were obtained before and at regular time intervals until 12 h after first dose administration. Results DMT plasma concentrations, scores in subjective and neurophysiological variables, and serum prolactin and cortisol were significantly higher after two consecutive doses. When effects were standardized by plasma DMT concentrations, no differences were observed for subjective, neurophysiological, autonomic, or immunological effects. However, we observed a trend to reduced systolic blood pressure and heart rate, and a significant decr…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-011-2434-x

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. First MB, Spitzer RL, Gibbon M, Williams JB (1999) Entrevista Clínica Estructurada para los Trastornos del Eje I del DSM-IV: Versión Clínica (SCID-VC). Masson, Barcelona

Cited by

See all 141

Metadata

Authors
dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J.
Affiliations
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
  • Universitat Autònoma de Barcelona (ES)
  • Hospital de Sant Pau (ES)
Venue
Psychopharmacology
Published
2011-08-13
Volume
219
Issue
4
Pages
1039-1053
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2062339243
Cited by
141
References
44
Citations by year
2026: 5 · 2025: 12 · 2024: 16 · 2023: 12 · 2022: 19 · 2021: 13 · 2020: 10 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 12 · 2015: 9 · 2014: 4 · 2013: 7 · 2012: 6
FWCI
5.87
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
ayahuasca, N,N-dimethyltryptamine, repeated dosing, acute tolerance, sensitization, prolactin, cortisol, growth hormone, cardiovascular effects, autonomic nervous system, neuroendocrine response, immune response, subjective effects
MeSH terms
Adult, Blood Pressure, N,N-Dimethyltryptamine, Double-Blind Method, Drug Administration Schedule, Drug Tolerance, Hallucinogens, Heart Rate, Humans, Male, Plant Extracts, Growth Hormone, Tea, Time Factors, Cross-Over Studies, Banisteriopsis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacology of ayahuasca administered in two repeated doses. https://app.cochat.ai/papers/10.1007/s00213-011-2434-x
The paper
dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J. (2012). Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology. https://doi.org/10.1007/s00213-011-2434-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.